www.newsmax.com
CVS to Pay $37.8 Million to Settle Claims Over Insulin Pens
CVS Health will pay $37.76 million to settle allegations it dispensed too many insulin pens to patients, and then obtained improper reimbursements from Medicare, Medicaid, and other government healthcare programs, U.S. Attorney Jay Clayton in Manhattan said on Tuesday.